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 2012 EMBO Molecular MedicineAnkyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, which is
characterized by cleft palate and severe defects of the skin, is an autosomal
dominant disorder caused bymutations in the gene encoding transcription factor
p63. Here, we report the generation of a knock-in mouse model for AEC syndrome
(p63þ/L514F) that recapitulates the human disorder. The AEC mutation exerts a
selective dominant-negative function on wild-type p63 by affecting progenitor
cell expansion during ectodermal development leading to a defective epidermal
stem cell compartment. These phenotypes are associated with impairment of
fibroblast growth factor (FGF) signalling resulting from reduced expression of
Fgfr2 and Fgfr3, direct p63 target genes. In parallel, a defective stem cell
compartment is observed in humans affected by AEC syndrome and in
Fgfr2b/ mice. Restoring Fgfr2b expression in p63þ/L514F epithelial cells by
treatment with FGF7 reactivates downstream mitogen-activated protein kinase
signalling and cell proliferation. These findings establish a functional link
between FGF signalling and p63 in the expansion of epithelial progenitor cells
and provide mechanistic insights into the pathogenesis of AEC syndrome.INTRODUCTION
The p63 gene encodes a tetrameric transcription factor belonging
to the p53 family, which has an essential function in the formation
of stratified epithelia. p63 expression is driven by two independent
promoters generating TA and DN classes of proteins, each
producing a, b or g ends as the result of alternative splicing eventster Academic Health
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alytowards the C-terminal region. The C-terminal end of thea isoform
contains a sterile-alpha-motif (SAM) domain and a transactivation
inhibitory domain, which are present in p63 and in p73 but absent
from p53 (Yang et al, 1998). p63 is expressed most abundantly in
the basal regenerative layers of stratified epithelia, whereDNp63a,
that can function either as an activator or a repressor, is the
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Giustina Ferone et al.Mice lacking the p63 gene die soon after birth with severe
defects of all stratified epithelia and their derivatives, facial
clefting and impaired limb formation (Mills et al, 1999; Yang
et al, 1999). Genome-wide profiling of p63 binding regions and
gene expression analyses have revealed that p63 directly
regulates a large number of genes (Della Gatta et al, 2008;
Kouwenhoven et al, 2010; Vigano et al, 2006; Yang et al, 2006).
p63 is critical for a number of cellular and developmental
processes in stratified epithelia, which include promoting cell
proliferation (Antonini et al, 2010; Senoo et al, 2007; Truong
et al, 2006), cell adhesion (Carroll et al, 2006; Koster et al, 2007)
and stratification (Koster et al, 2004; Truong et al, 2006), while
at the same time suppressing terminal differentiation (Nguyen
et al, 2006). In addition, p63 is required, at least in vitro, for the
proliferative potential of self-renewing populations of corneal
and epidermal stem cells (Rama et al, 2010; Senoo et al, 2007)
and in vivo for thymic epithelial cells (Senoo et al, 2007).
At least five human malformation syndromes resulting from
heterozygous mutations in p63 exhibit phenotypes that are
reminiscent of those displayed by p63/ mice although they
are less severe. Ankyloblepharon-ectodermal defects-cleft lip/
palate (AEC) syndrome (or Hay–Wells syndrome; OMIM 106260)
is caused by mutations clustered mostly in the SAM domain.
AEC syndrome differs from other conditions resulting from p63
mutations, in the severity of the skin phenotype, the occurrence of
ankyloblepharon and the absence of ectrodactyly (Dishop et al,
2009; McGrath et al, 2001). Dermatological features include mild
atrophy, often associated with congenital erythroderma, wide-
spread skin erosions at or soon after birth and ectodermal
dysplasia (Dishop et al, 2009; Fete et al, 2009; Julapalli et al, 2009).
Investigation of the pathogenesis of AEC syndrome has been
hampered by the lack of an animal model closely resembling the
human disorder. To this aim, we generated the p63þ/L514F
mouse, a faithful mouse model of AEC syndrome, which is
characterized by hypoplastic and fragile skin, ectodermal
dysplasia and cleft palate. We find that epidermal hypoplasia
and cleft palate are associated with a transient reduction in
epithelial cell proliferation during development. These defects
closely resemble those observed in the Fgfr2b/ mice (De
Moerlooze et al, 2000; Petiot et al, 2003; Rice et al, 2004). p63
transcriptionally controls the FGF receptors Fgfr2 and Fgfr3 and
their expression as well as downstream signalling is affected
in p63þ/L514F mutant mice. We propose that impaired FGF
signalling downstream of p63 is likely an important determinant
of reduced ectodermal cell proliferation and defective self-
renewing compartment in AEC syndrome.RESULTS
The phenotype of p63R/L514F mice mimics that of AEC
syndrome
To characterize the developmental alterations that occur in AEC
syndrome, we generated a knock-in mouse model carrying a
leucine to phenylalanine substitution in position 514 (L514F) in
the p63 protein (Fig 1A–D). L514 is a highly conserved amino
acid in the first helix of the SAM domain, which is mutated towww.embomolmed.org EMBO Mol Med 4, 192–205either phenylalanine or valine in AEC patients (McGrath et al,
2001; Payne et al, 2005; Supporting Information Fig S1A). A
correctly targeted embryonic stem cell line allowed themutation
to be transmitted through germline to produce heterozygous
p63þ/L514F mice. p63 messenger RNA (mRNA) was expressed
at similar levels in p63þ/L514F mutant and in wild-type
epidermis (Supporting Information Fig S1B), whereas p63
protein was more abundant in mutant than in wild-type
epidermis (Supporting Information Fig S1C-D) consistent with
the previously reported p63 accumulation in the skin of AEC
patients (Browne et al, 2011; Moretti et al, 2010). No aberrant
isoforms were detected either at the RNA or the protein levels
(Supporting Information Fig S1C and S1E).
Visual inspection at birth revealed that newborn p63þ/L514F
mice exhibited air accumulation in their stomach and
intestine without milk uptake and the mice died shortly after
birth. p63þ/L514F mice (n¼ 187) exhibited a fully penetrant
wide cleft of the secondary palate without involvement of the
lip/primary palate or other cranial ormandibularmalformations
(Fig 1E; Supporting Information Fig S2A–C). Cleft palate was not
rescued by crossing chimeras with females of different inbred
strains (see Supporting information) suggesting that this defect
was independent of the genetic background.
Ankyloblepharon-ectodermal defects-cleft lip/palate patients
are characterized by mild atrophy of the skin, skin erosions and
sparse or absent hair (Dishop et al, 2009; McGrath et al, 2001).
p63þ/L514F mice displayed reduced skin folding and a translucent
appearance of the skin at birth (Supporting Information Fig S3A).
At the histological level, mutant skin was thinner than that of wild-
type mice with consistently thin epidermis and dermis (Fig 1F).
Blistering skin lesions, localized mainly between the basal and
suprabasal layers of the epidermis, were observed in a fraction of
mutant mice (21%; n¼ 28) (Supporting Information Fig S3B). The
number of hair follicles in more advanced stages of differentiation
was reduced (Fig 1F and Supporting Information Fig S3C). In spite
of normal hair placode formation, hair follicle morphogenesis was
delayed (Supporting Information Fig S3C-D). Vibrissae were
similarly shortened (Supporting Information Fig S3E). Among the
dental abnormalities observed in AEC patients are smaller teeth,
with small occlusal surface in premolars and molars (Farrington &
Lausten, 2009). Similarly, in p63þ/L514F mice the crown of the
lower first molar tooth was smaller than the wild-type, particularly
in the mesial–distal axis, and the distal cusp was missing (Fig 1G).
In addition, the tooth germ was smaller with less developed cusps
and with hypoplastic pre-ameloblast and odontoblast layers
(Fig 1H). Ankyloblepharon, a characteristic defect in AEC patients,
could not be evaluated in mutant mice as eyelids are normally
fused until postnatal day 15 (P15).
Taken together, these data show that p63þ/L514F heterozygous
mice phenocopy many aspects of the human AEC syndrome and
thus represent the first mouse model for this disease.
Palate hypoplasia and reduced cell proliferation of the
palatal epithelium in p63R/L514F mice
To identify the cause of cleft palate, we analyzed the p63þ/L514F
mouse oral cavity during development. At embryonic day
(E)13.5, although reproducibly smaller, the mutant palatal 2012 EMBO Molecular Medicine 193
Research Article
Defective FGF signalling in AEC syndrome
Figure 1. Generation and phenotype of p63R/L514F
mice.
A. Gene targeting strategy used to generate the
p63þ/L514F knock-in mice. The L514F mutation is
indicated with . Dotted black lines indicate the
sizes of the fragments generated from each allele
upon EcoRI (E) digestion. Oligonucleotide primers
(arrows) used for PCR analysis and the relative PCR
product length, are indicated.
B. Southern blot analysis of ES cell clones using the
EcoRI digestion of genomic DNA and the 50 probe
upstream of the recombinant targeted site.
C. DNA sequencing analysis of the L514F point
mutation in properly targeted ES cells.
D. In vivo removal of the NEO cassette obtained by
crossing chimeras with CMV-Cre transgenic mice,
as revealed by PCR analysis performed on tail
genomic DNA using one forward (F) and two
reverse primers (R1 and R2).
E. H&E staining of sagittal sections of þ/þ and
p63þ/L514F newborn heads. Cleft of the secondary
palate is indicated by the arrow.
F. H&E staining of dorsal skin of p63þ/L514F mice at
P0. Mutant epidermis is thinner and with less
developed hair follicles.
G. Three-dimensional computer-aided reconstruction
of tooth crown morphology of the first lower molar
at P0. The cusps are numbered as buccal (B1, 2, 3),
lingual (L1, 2, 3) and distal (4). The axis of the tooth
coming in contact with adjacent teeth is indicated:
mesial (M) and distal (D). Scale bar: 400mm.
H. Histological analysis of sagittal sections of the first
lower molar at P0. EO, enamel organ; DP, dental
papilla; AM, ameloblasts; OD, odontoblasts. Scale
bar: upper panel 50mm, lower panel 40mm.
194shelves pointed downwards on either side of the tongue similar
to their wild-type littermates (Fig 2A, C and D). Although the
mutant palatal shelves elevated appropriately at E14.5, they
were smaller, widely spaced and failed to meet in the midline
(Fig 2B).
To test the possibility that the smaller size of the palatal
shelves may result from reduced cell proliferation, we measured
5-bromodeoxyuridine (BrdU) incorporation between E13 and
E13.5, the narrow timewindow during whichmost of the palatal
shelf outgrowth occurs. At E13, cell proliferation was reduced
significantly in the mutant epithelium and to a lesser extent in 2012 EMBO Molecular Medicinethe mesenchyme (Fig 2E and F). At E13.5, BrdU incorporation
was unaffected in the mesenchyme, but was still reduced
significantly in the epithelium (Fig 2F).
Consistent with the reduced proliferation observed, the
p63þ/L514F palatal epithelium appeared disorganized and
hypoplastic with irregularly spaced basal cells expressing p63
and keratin 14 (Krt14). Basal cells were intermingled with Krt17-
and Krt8-positive periderm cells, which lacked the characteristic
flattened morphology observed in wild-type mice (Fig 2G).
To test whether the disorganization of the epithelium could
affect palatal fusion, we placed E13.5 palatal shelves with theirEMBO Mol Med 4, 192–205 www.embomolmed.org
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Figure 2. Palatal shelf hypoplasia and reduced
epithelial cell proliferation in p63R/L514F embryos.
A. H&E staining of coronal sections of p63þ/L514F
mid palate at E13.5 reveals grossly similar
morphology of palatal shelves compared to
controls. t, tongue; p, palatal shelf; tb, molar
tooth bud; m, mandible. Scale bar: 200mm.
B. H&E and Alcian Blue staining of coronal sections
of p63þ/L514Fmid palate at E14.5 reveals a failure
of the palatal shelves to meet in the horizontal
plane. nc, nasal cavity. Scale bar: 200mm.
C. A closer view of H&E staining of E13.5 coronal
sections reveals that mutant palatal shelves are
hypoplastic compared to controls. Scale bar:
50mm.
D. Quantification of the anterior, mid and posterior
palatal shelf area. Error bars represent standard
deviation (SD). Anterior palate
p-value¼ 0.00032; n¼ 9. Mid palate
p-value¼ 0.00079; n¼ 9. Posterior palate
p-value¼ 0.0097; n¼9.
E. Immunofluorescence with anti-BrdU antibodies
at E13 (left panel) reveals reduced proliferation
of mutant palatal shelves.
F. The average percentage of BrdU incorporation is
reduced in mutant palatal epithelium at E13 and
E13.5. Epithelium at E13 p-value¼ 0.009; n¼9.
Mesenchyme at E13 p-value¼ 0.032; n¼9.
Epithelium at E13.5 p-value¼0.018; n¼ 9. Data
are represented as mean SD. Scale bar: 50mm.
G. Double immunofluorescence staining for the
indicated markers reveals hypoplasia and dis-
organization of the palatal shelf epithelium at
E13.5. Scale bar: 20mm.
H. Palatal explant culture assay reveals that mutant
palatal shelves fuse appropriately. Palatal
shelves freshly isolated at E13.5 were placed in
contact and cultured for 48 h. ne, nasal
epithelium; oe, oral epithelium.medial edge epithelia in contact in culture. All explants fused
appropriately (Fig 2H; n¼ 9), suggesting that the cleft palate in
mutant mice is unlikely to be caused by a fusion failure.
Thus, in p63þ/L514 embryos cleft palate is caused by reduced
cell proliferation as well as disorganization of the p63-
expressing epithelium and consequent reduction of mesench-
ymal cell proliferation with insufficient extension of the palatal
shelves toward the midline.
Epidermal hypoplasia and defective cell proliferation
in p63R/L514F embryos
Severe hypoplasia was also observed in p63þ/L514F epidermis
(40% thinner than wild-type) during embryonic development
and at birth, with a reduction in the number of nuclei and amore
flattened appearance of cells in all layers (Fig 3A and B). In
contrast, no hypoplasia was observed in epidermis of micewww.embomolmed.org EMBO Mol Med 4, 192–205heterozygous for a null mutation in p63 (p63þ/) (Supporting
Information Fig S4A).
Differentiation markers were localized appropriately in
neonatal and in developing mutant epidermis although each
layer was hypoplastic compared to wild-type (Fig 3C; Support-
ing Information Fig S4B). Expression of these markers was
quantitatively similar in wild-type and in mutant epidermis
when cell extracts normalized for protein content (Fig 3D).
Consistent with a normal differentiation process, the imperme-
able epidermal barrier was established at the appropriate
developmental time-point in p63þ/L514F embryos (Supporting
Information Fig S4C), despite the epidermal hypoplasia.
To test whether epidermal hypoplasia could be due to
defective cell proliferation, we performed in vivo BrdU labelling
at different embryonic stages. A statistically significant reduc-
tion in BrdU incorporation was detected in mutant epidermis at 2012 EMBO Molecular Medicine 195
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Figure 3. p63R/L514F epidermis is hypoplastic compared to the control.
A. H&E staining reveals hypoplasia of p63þ/L514F epidermis at the indicated
times of development. Dashed lines indicate the border between epi-
dermis (top) and dermis (bottom). Scale bar: 50mm.
B. Quantification of epidermal thickness (mm) in þ/þ and p63þ/L514F skin at
birth (p-value¼0.0009; n¼ 6). Data are represented as mean SD.
C. Immunofluorescence analysis for p63, Krt14 (basal layer), Krt10 (spinous
layer), and loricrin (Lor, granular layer) at P0 reveals appropriate expression
of these differentiation markers in mutant epidermis. Scale bar: 20mm.
D. Immunoblotting of total cell extracts from neonatal epidermis using
antibodies against the indicated differentiation markers, Krt1 (spinous
layer), the upper spinous layer marker involucrin (Ivl), the adherens
junction component E-cadherin (Cdh1) and aTubulin (Tub) as loading
control.
E. BrdU staining of the epidermis reveals reduced proliferation in mutant
epidermis during development. Left panels: BrdU positive cells are in red;
nuclei are stained with DAPI. Dashed lines indicate the border between
epidermis (top) and dermis (bottom). Scale bar: 50mm. Right panel: BrdU
positive cells are expressed as percentage of the total number of basal cells
(E13.5 p-value¼0.0151; n¼ 7. E16.5 p-value¼ 0.0271; n¼7). Data are
represented as mean SD.
F. Left panel: immunofluorescence for active caspase 3 at P0 showing low levels
of apoptosis in p63þ/L514F epidermis compared to wild-type. Arrows indicate
apoptotic cells. Scale bar: 70mm. Right panel: quantification of active caspase
3 positive cells. Data are represented as mean SD (p-value¼ 0.0010;
n¼16).
196  2012 EMBO Molecular Medicineboth E13.5 and E16.5 (Fig 3E). In contrast, at E18.5 the rate
of BrdU incorporation was similar in mutant and wild-type
epidermis in spite of persistent epidermal hypoplasia (Fig 3E).
Apoptosis was a very rare event in p63þ/L514F epidermis as
determined by staining for active caspase 3 at E16.5 and P0
(Fig 3F and Supporting Information Fig S5A) or by fluorescent
activated cell sorting (FACS) analysis with annexin V antibodies
of freshly isolated keratinocytes (Supporting Information
Fig S5B). The apoptotic rate was modestly increased in mutant
versus wild-type epidermis. Thus, in p63þ/L514F epidermis,
hypoplasia is associated with a transient reduction of cell
proliferation during embryonic development and a modest
increase in apoptosis, whereas terminal differentiation is not
significantly affected.
Fgfr2b and Fgfr3b expression is downregulated in
p63R/L514F mice
To gain insight into the molecular mechanisms underlying the
proliferative defects observed in the developing palate and skin,
we compared gene expression profiles of mutant and wild-type
cells or tissues derived from E14.5 skin, E18.5 epidermis and
newborn primary keratinocytes. These data were also compared
with previously obtained gene expression profiles of p63 knock-
down versus control keratinocytes (Della Gatta et al, 2008).
Several known p63 target genes were affected to a similar extent in
p63þ/L514F cells or tissue and in p63 knockdown keratinocytes
compared to the appropriate controls (Supporting Information
Table S1). However, the expression of selected cell cycle regulators
that have been previously implicated in p63-mediated cell cycle
progression, including p21Cip1/Waf1 (Nguyen et al, 2006; Truong
et al, 2006), p16Ink4a, p19Arf (Su et al, 2009) and the micro-RNA
miR-34a (Antonini et al, 2010), was unaffected in E14.5 mutant
skin or in primary keratinocytes (Supporting Information Fig S6A),
suggesting that reduced proliferation in mutant epidermis was
unlikely to depend on their direct regulation.
FGF signalling is a prominent pathway that controls epithelial
cell proliferation during embryonic development. Fgfr2b/
mice, which lack the epithelial-specific Fgfr2b isoform, display
epidermal hypoplasia associated with a transient reduction of
cell proliferation during development, tooth and hair defects
and cleft palate with reduced palatal epithelial cell proliferation
(De Moerlooze et al, 2000; Petiot et al, 2003; Rice et al, 2004).
Interestingly, Fgfr2b expression is reduced in the developing
epidermis and in thymus of p63/ mice (Candi et al, 2007;
Fomenkov et al, 2003; Laurikkala et al, 2006) and is affected by
mutant p63 and by p63 knockdown in the global gene
expression analysis (Supporting Information Table S1).
To provide further support for Fgfr2b or other FGF signalling
components being affected in p63þ/L514F embryos, we first
measured the expression levels of FGF receptors in mutant and
wild-type tissues. Fgfr2b mRNA was significantly reduced in
p63þ/L514F palatal shelves, skin and primary keratinocytes as
compared to controls (Fig 4A and B), whereas its expressionwas
unaffected in p63þ/ skin (Supporting Information Fig S6B).
Among the other FGF receptors, expression of the epidermal-
specific isoform Fgfr3b, which plays a role in promoting both
epidermal cell proliferation and differentiation (MandinovaEMBO Mol Med 4, 192–205 www.embomolmed.org
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Figure 4. Fgfr2 and Fgfr3 are direct p63 target
genes.
A. Real-time RT-PCR performed on total mRNA
isolated from palatal shelves at E13.5, embryonic
skin at E14.5, and from neonatal keratinocytes,
reveals reduced expression of Fgfr2b in
p63þ/L514F tissues compared to þ/þ controls.
Data are normalized for b-actin mRNA levels and
are represented as mean SD normalized mRNA
levels (palate p-value¼0.0015; n¼9, skin
p-value¼0.00044; n¼8; keratinocytes
p-value¼0.0098; n¼ 7) and Fgfr3b (palate
p-value¼0.0112; n¼ 8; skin p-value¼0.0092;
n¼8; keratinocytes p-value¼ 0.0002; n¼6).
B. Immunostaining for Fgfr2 (red) reveals its
reduced expression in mutant embryonic skin at
E15.5 compared to control. Nuclei are stained
in blue. Scale bar: 20mm.
C. Real-time RT-PCR for Fgfr2 pre-mRNA reveals
reduced expression of the primary transcript in
p63þ/L514F keratinocytes compared to þ/þ
controls. Data are represented as mean SD
(p-value¼ 0.023; n¼ 3). To control for genomic
DNA contamination, reverse transcriptase (RT)
was not added in the indicated samples.
D. ChIP assay of mouse keratinocyte chromatin using
mouse p63 polyclonal antibodies and rabbit IgG as
negative control reveals strong p63 binding to
Fgfr2 (þ1.8kb from TSS) and Fgfr3 (10kb from
TSS) regulatory regions. The result is representative
of three independent experiments, and error
bars represent standard error (SE).
E. ChIP assay of E14.5 skin chromatin reveals a
similar p63 binding to Fgfr2 and Fgfr3 regulatory
regions. The control regions (ctr) were at130 bp
from TSS and8.5 kb from TSS in Fgfr2 and Fgfr3,
respectively. Data are represented as mean SE
and are representative of at least three inde-
pendent experiments.
F. Luciferase assay of the Fgfr2 regulatory region in
H1299 reveals that p63 can enhance the wild-
type (WT) region activity but not the mutant
(MUT) one in cells devoid of p63. See Supporting
Information Table S3 for the p63 binding site
mutation.
G. Luciferase assay in H1299 reveals that mutant
p63L514F is unable to transactivate the Fgfr2
regulatory region and interferes with wild-type
p63 affecting its transactivation ability. Data are
represented as mean SE and are representative
of at least three independent experiments.et al, 2009), was significantly reduced in p63þ/L514F tissue and
cells as compared to p63þ/ and wild-type controls (Fig 4A). In
contrast, Fgfr1 and Fgfr4 were expressed equally in mutant and
wild-type embryonic tissues (Supporting Information Table S2).
Fgfr2 and Fgfr3 are p63 transcriptional target genes
To assess whether the Fgfr2 primary transcript was affected in
p63 mutant mice, we measured the relative levels of unspliced
Fgfr2 RNA (pre-mRNA) by amplifying segments of Fgfr2 introns.
In mutant keratinocytes, Fgfr2 pre-mRNA and total Fgfr2mRNA
were similarly reduced compared to the wild-type indicatingwww.embomolmed.org EMBO Mol Med 4, 192–205that the p63 mutation is likely to affect primarily Fgfr2 gene
transcription (Fig 4A and C). In addition, Fgfr2 and Fgfr3
expression was measured in p63 knockdown mouse keratino-
cytes at different times after transfection with p63-specific
siRNA. Both Fgfr2b and Fgfr3b were rapidly reduced upon p63
knockdown, whereas the gene encoding the FGF binding protein
Fgfbp1, which was also affected in p63þ/L514F epidermis, was
reduced only at later time points (Supporting Information Fig
S6C; Supporting Information Table S1).
To identify p63 binding sites within the Fgfr2 and Fgfr3 genomic
loci, we analyzed chromatin immunoprecipitation, followed by 2012 EMBO Molecular Medicine 197
Research Article
Defective FGF signalling in AEC syndrome
198deep sequencing (ChIP-seq) data obtained in human primary
keratinocytes (Kouwenhoven et al, 2010). Several p63 binding
regions were observed in the Fgfr2 and Fgfr3 loci, whereas no p63
binding regions were detected in Fgfr1 and Fgfr4 loci (Supporting
Information Fig S7A and S8A; Kouwenhoven et al, 2010). In the
Fgfr2 locus, four p63 binding regionswere evolutionary conserved
in mouse and were enriched for histone H3 methylation on lysine
4 mono- and di-methylations (H3K4me1 and me2), chromatin
marks known to associatewith distal regulatory regions [reviewed
in (Bell et al, 2011)], suggesting that they function as regulatory
elements (Supporting Information Fig S7A). ChIP assays ofmouse
primary keratinocytes under growing conditions demonstrated
p63 binding to the corresponding mouse sequences, the strongest
binding region being the þ1.8 kb region from the Fgfr2
transcriptional start site (TSS) (Fig 4D; Supporting Information
Fig S7B). p63 binding at the þ1.8kb was also detected in vivo in
E14.5 skin extracts (Fig 4E), and in E13.5 mouse palatal shelves
(ChIP-seq data; J.D., H.Z., unpublished observations). In addition,
the þ1.8 kb region was strongly enriched for trimethylated H3K4
(H3K4me3) (Supporting Information Fig S7C) that mark sites of
transcriptional activation near the 50 region of actively transcribed
genes (Bell et al, 2011), supporting the possibility that this region
plays an active role in gene transcription regulation.
Sequence analysis of theþ1.8 kb p63 binding region revealed
the presence of a ‘canonical’ p63 binding site that was conserved
in mammals (Supporting Information Fig S7D). A luciferase
reporter construct encompassing the p63 binding region was
induced significantly by p63 overexpression in human H1299
cells lacking p63, and its response was abolished by a point
mutation in the p63 binding site (Fig 4F). Mutant p63L514F was
unable to transactivate the Fgfr2 promoter to the same extent as
wild-type p63, and co-expression of mutant and wild-type p63
suppressed wild-type p63-mediated transactivation of the Fgfr2
promoter (Fig 4G). Taken together, these data indicate that p63
directly activates Fgfr2 expression in primary mouse keratino-
cytes and in embryonic skin.
Similarly, we identified a p63 binding region in the FGFR3
genomic locus at10 kb from the TSS on human chromosome 4
that was evolutionary conserved in mouse (Supporting
Information Fig S8A; Kouwenhoven et al, 2010). Binding to
this region of the genome was observed by ChIP in primary
human and mouse keratinocytes and in E14.5 embryonic skin
(Fig 4D and E; Supporting Information Fig S8B). In addition, this
region was enriched for H3K4me1 (Supporting Information Fig
S8C). A conserved p63 binding site was found in the 10 kb
region (Supporting Information Fig S8D). Luciferase assays
revealed that the p63 binding region activity was efficiently
induced by p63 expression in H1299 cells (Supporting
Information Fig S8E).
These data indicate that Fgfr2 and Fgfr3 are bona fide p63
transcriptional target genes.
FGF signalling pathway is disrupted in p63R/L514F
keratinocytes
To determine the contribution of Fgfr2b and Fgfr3b down-
regulation to FGF signalling and cell proliferation, we measured
the levels of FGFR substrate 2a (FRS2a) tyrosine phosphorylation. 2012 EMBO Molecular MedicineIn p63þ/L514F primary keratinocytes, a strong reduction of Fgfr2b
and Fgfr3b proteins was accompanied with a significant decrease
in FRS2a phosphorylation (Fig 5A) indicating impaired activation
of FGF signalling. FGF signalling leads to induction of the classical
Ras/extracellular signal regulated kinase (ERK) pathway. In spite
of impaired FGF receptor activity, ERK phosphorylation was
unaffected in p63þ/L514F keratinocytes. The presence of several
other growth factors in the fully supplemented medium in which
cells were grown may compensate for the impaired FGF receptor
activity. In contrast, treatment of starved wild-type cells with KGF
(keratinocyte growth factor or FGF-7), the Fgfr2b-specific ligand,
resulted in ERK phosphorylation, whereas in mutant keratino-
cytes, ERK phosphorylation was impaired (Fig 5B). Restoring
Fgfr2b expression by retroviral Fgfr2b transfer rescued ERK
activation upon KGF treatment. As expected, EGF treatment
elicited a similar induction in ERK phosphorylation in both wild-
type and mutant keratinocytes, and exogenous Fgfr2b expression
had no effect on EGF-induced ERK phosphorylation (Supporting
Information Fig S9A) indicating a specific impairment of FGF/Ras/
ERK pathway activation in mutant cells.
Consistent with the normal rate of cell proliferation observed
in neonatal skin (Fig 3E), mutant keratinocytes proliferated
under growing conditions at a rate that was indistinguishable
from that of wild-type cells (Supporting Information Fig S9B).
However, in the absence of other growth factors, the rate of
BrdU incorporation after KGF stimulation was reduced to 50%
in mutant compared to wild-type cells. Restoring Fgfr2b
expression by retroviral Fgfr2b transfer resulted in a significant
rescue of BrdU incorporation upon KGF treatment (Fig 5C).
Taken together, these data indicate that downstream FGF
signalling is impaired in p63þ/L514F keratinocytes, and exogen-
ous expression of the Fgfr2b receptor is sufficient to restore
mitogen-activated protein kinase (MAPK) signalling and BrdU
incorporation following KGF stimulation.
Reduced number of epidermal self-renewing cells
in p63R/L514F and in Fgfr2b/ mutant epidermis
Loss of p63 has been reported to affect the proliferative potential
of stratified epithelial stem cells, including those of the skin
(Senoo et al, 2007). To explore the possibility that mutant p63
may affect the pool of epidermal self-renewing cells, we first
tested whether p63þ/L514F cells have an altered clonogenic
potential by plating freshly isolated newborn keratinocytes at
clonogenic density and analyzing their ability to form clones
over time. Initial plating efficiency was similar between mutant
and wild-type cells. However, after 3 weeks in culture the
number of large clones (>2mm) generated by p63þ/L514F cells
was significantly lower than their wild-type counterparts
(Fig 6A). Under clonogenic conditions, the overall mutant
population was less proliferative (Supporting Information Fig
S10A) consistent with a reduced number of clonogenic cells or
with a reduced ability to proliferate under clonogenic condi-
tions. However, no differences in cell proliferation were
detected between p63þ/L514F mutant and wild-type large clones
3 weeks after plating in spite of a maintained reduction in Fgfr2
protein expression (Supporting Information Fig S10B-C).
Accordingly, Fgfr2b/ keratinocytes had a very similarEMBO Mol Med 4, 192–205 www.embomolmed.org
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Figure 5. Rescue of FGF signalling by exogenous Fgfr2b expression in
mutant epidermal cells.
A. Immunoblotting analysis for Fgfr2, Fgfr3 and the phosphorylated active
form of the downstream signalling proteins FRS2a (p-FRS2a) and ERK
(p-ERK) reveals downregulation of the FGF receptor and downstream
signalling in p63þ/L514F keratinocytes compared to controls. Tubulin was
used to normalize samples for protein content.
B. Immunoblotting analysis for ERK phosphorylation reveals reduced ERK
activation in p63þ/L514F starved keratinocytes compared to controls upon
KGF treatment. Exogenous expression of Fgfr2b and concomitant treat-
ment with KGF can restore ERK phosphorylation. Total ERK protein levels
were used as control. pFRS2a was used as control of FGFR activation.
C. BrdU incorporation of starved keratinocytes treated as in (B) reveals that
p63þ/L514F cells have a defective cell proliferation in the absence of
exogenous growth factors. Rescue is obtained by exogenous expression of
Fgfr2b and concomitant treatment with KGF (25% difference between
mock-infected untreated samples and KGF treated/Fgfr2b expressing cells;
p-value¼ 0.005, n¼ 6 of three independent experiment). Data are
represented as mean SD.
www.embomolmed.org EMBO Mol Med 4, 192–205reduction in the number of large clones (>2mm) compared to
wild-type controls in spite of a similar initial plating efficiency
(Fig 6B).
To test whether the self-renewal capacity of p63þ/L514F and
Fgfr2b/ cells was impaired, a secondary and tertiary plating
strategy was employed. Clones were picked individually and
disaggregated cells were cultured for 3 weeks at clonogenic
density for two consecutive passages. p63þ/L514F keratinocytes
generated secondary and tertiary large clones with a similar
efficiency to that of the wild-type (Fig 6D; n¼ 34) in spite of
persistent p63L514F mutant expression in tertiary clones
(Supporting Information Fig S10D), revealing that the intrinsic
self-renewal ability of mutant cells was unaffected. Similarly,
Fgfr2b/ large clones were passaged with a somewhat reduced
but still high efficiency compared to the wild-type, indicating
that the intrinsic self-renewal ability of Fgfr2b/ cells was only
modestly affected. These data are consistent with the possibility
that neonatal p63þ/L514F and Fgfr2b/ skin contains a reduced
number of clonogenic cells with a similar self-renewal ability
compared to wild-type.
The stem cells of the interfollicular epidermis have long been
thought to reside in the basal layer, however, their identity is
still elusive, and there are no definitive markers for these cells
[reviewed in (Fuchs, 2009; Watt & Jensen, 2009)]. In contrast,
various populations of hair follicle stem cells have been
characterized in great detail. Hair bulge stem cells expressing
high levels of a6 integrin (Itga6bri) and low levels of the
transferrin receptor CD71 (CD71dim) are enriched for cells with a
higher clonogenic potential both in vitro and in vivo (Tani et al,
2000; Tumbar et al, 2004). Consistent with these previous
reports, the Itga6bri/CD71dim population had an enhanced
ability to form large clones in a clonogenicity assay (Supporting
Information Fig S10E). In wild-type skin, the Itga6bri/CD71dim
population constituted 0.5% of the total epidermal cells using
stringent criteria (Supporting Information Fig S10F). In contrast,
the Itga6bri/CD71dim population was significantly reduced in
p63þ/L514F epidermis, representing only 0.1% of the total,
suggesting that the clonogenic cell population is reduced in
mutant skin.
To further evaluate the presence of cells with high-proliferative
potential in mutant skin, we immunostained neonatal skin for
markers that have been shown to correlate with these cells, such
as Krt15 (Liu et al, 2003; Stachelscheid et al, 2008) and Sox9
(Nowak et al, 2008; Vidal et al, 2005). Krt15 expression was
dramatically reduced in p63þ/L514F and in Fgfr2b/ neonatal
epidermis and hair follicle as assessed by immunofluorescence
and, for p63þ/L514F epidermis, also by immunoblotting (Fig 7A
and B). Importantly, a similar strong downregulation of Krt15
was also observed in AEC patient skin by immunofluorescence
and by real-time RT-PCR (Fig 7C and D). Similarly, Sox9 was
strongly reduced in p63þ/L514F and Fgfr2b/ hair follicles even in
the rare well-formed follicles containing a visible bulge region
(Fig 7E). A significant reduction of Sox9mRNAwas also detected
in skin samples derived fromAEC patients compared to wild-type
controls (Fig 7F).
Taken together, these data indicate that neonatal skin of
p63þ/L514F mice has a significant reduction in the number of 2012 EMBO Molecular Medicine 199
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Figure 6. The epidermal self-renewing compartment
is reduced in p63R/L514F mice.
A. Clonogenicity assay performed with freshly isolated
epidermal cells cultured for 3 weeks reveals a
reduced clonogenic potential of p63þ/L514F kerati-
nocytes.
B. Left panel: Percentage of total number of p63þ/L514F
compared to þ/þ clones. The difference is not
statistically significant. Right panel: A reduction in
clones larger than 2mm is observed in p63þ/L514F
mice compared to þ/þ. Data are represented as
mean SD (p-value¼ 0.0076; n¼6).
C. Clonogenicity assay performed with freshly isolated
Fgfr2b/ and þ/þ keratinocytes cultured for 3
weeks. Clonogenicity assay reveals a reduction in the
number of clones with a high-clonogenic potential
(>2mm) in Fgfr2b/ mice compared to wild-type.
Data are represented as mean SD
(p-value¼0.035; n¼6).
D. Secondary and tertiary replating of clones reveals
that p63þ/L514F epidermal cells can self-renew sim-
ilarly to þ/þ in tertiary cultures. The percentage of
secondary clones that formed tertiary clones is
indicated (þ/þ n¼37; p63þ/L514F¼ 27; Fgfr2/
n¼19).
200epithelial cells with high-clonogenic and -proliferative potential,
and that in spite of the quite different structure of the human
skin, reduced expression of Krt15 and Sox9 is also observed in
the skin of AEC patients. Fgfr2b is required for the epidermal
self-renewing compartment suggesting that impairment of the
FGF signalling may account for a reduced number of epidermal
cells with high-proliferative potential in p63þ/L514F skin.DISCUSSION
Here, we generated amousemodel for AEC syndrome that closely
mimics the human disorder at the genetic and phenotypic levels. 2012 EMBO Molecular MedicineAmong the various processes regulated by p63, we find that the
AEC mutant affects primarily ectodermal cell proliferation during
development through a highly selective mechanism, leading to
epidermal and palatal hypoplasia and reduced expansion of
epithelial progenitor cells. In addition, our work demonstrates a
novel functional link between p63 and FGF signalling in
controlling progenitor cell expansion providing significant
mechanistic insights into the pathogenesis of AEC syndrome.
p63þ/L514F epidermis is hypoplastic and hypoproliferative
during embryonic development. In contrast, cell proliferation is
unaffected at birth in spite of persistent hypoplasia. This is an
unusual phenotype that has been reported only for Fgfr2b/
mice (Petiot et al, 2003) suggesting that the underlyingEMBO Mol Med 4, 192–205 www.embomolmed.org
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Figure 7. Reduced progenitor marker expression in p63R/L514F and Fgfr2b/ mice and in skin of AEC patients.
A. Immunostaining reveals reduced Krt15 expression (green) in the epidermis and in the hair follicle of p63þ/L514F and Fgfr2b/ compared toþ/þ control. Nuclei
are stained with DAPI. Scale bar: 50mm.
B. Immunoblotting for Krt15 confirms decreased protein expression in p63þ/L514F epidermis compared to þ/þ. Tubulin was used to normalize samples.
C. Immunostaining for Krt15 (green) of skin biopsies from AEC patients (AEC1 and AEC2) and a human unaffected control (CTR) demonstrates reduced Krt15
expression in AEC skin. Scale bar: 50mm.
D. Real-time RT-PCR for Krt15 mRNA in human skin isolated from AEC patients or controls (CTR) reveals a quantitative reduction of Krt15 mRNA levels in the skin
of AEC patients compared to wild-type. Data are represented as mean SD (p-value¼0.026).
E. Immunofluorescence for Sox9 on neonatal mouse skin reveals reduced Sox9 expression in p63þ/L514F and Fgfr2b/ compared toþ/þ control. Scale bar: 50mm.
F. Levels of Sox9 mRNA in human skin isolated from AEC patients or controls (CTR) were assessed by real-time RT-PCR. Data are represented as mean SD (p-
value¼3.85105).mechanism is common between these two mutants. In addition,
a similar reduction of the self-renewing compartment is
observed in p63þ/L514F and in Fgfr2b/ skin, implicating Fgfr2b
and FGF signalling in epidermal progenitor cell expansion and/
or specification for the first time.While the number of epidermal
progenitors with stemness properties is reduced, their intrinsic
self-renewal ability appears unaffected as judged by long-term
replating assays. In vivo competition experiments will be
required to determine the exact nature of the defect in the
self-renewing epithelial compartments.
The lack of bona fide markers for interfollicular epidermal
stem cells has prevented us from fully demonstrating that not
only hair follicle stem cells but also interfollicular stem cells are
defective. However, it is tempting to speculate that a defective
epidermal self-renewal compartment may also be a likely
contributor to the neonatal epidermal hypoplasia in p63þ/L514F
mice and possibly in humans affected by AEC syndrome.
As discussed above, skin and palate defects in p63þ/L514F
embryos are similar, albeit less severe, to those observed
in Fgfr2b/ embryos. However, some defects observed inwww.embomolmed.org EMBO Mol Med 4, 192–205embryos lacking Fgfr2b, including limb and lung defects, are not
observed or are observed to a much lesser extent in
p63þ/L514F embryos (De Moerlooze et al, 2000; Revest et al,
2001). We speculate that in some tissues, p63 may not be the
main regulator of Fgfr2b expression or reduced Fgfr2b levels
may be still sufficient to allow normal development. In addition,
some defects observed in p63þ/L514F embryos are not observed
in Fgfr2b/ embryos suggesting that other p63 target genes
affected by AEC mutations may also contribute to the
phenotype. This may be the case of ankyloblepharon, a
characteristic defect of AEC syndrome, not found in Fgfr2b/
mice, which on the contrary display absence of eyelids (De
Moerlooze et al, 2000; Revest et al, 2001). Similarly, epidermal
adhesion defects are observed in p63þ/L514F newborn mice but
not in Fgfr2b/ mice. A previously described mouse model for
AEC syndrome obtained by conditional DNp63 knockdown in
epidermis is affected by skin erosions and by focal disruption of
the basement membrane (Koster et al, 2009), which was not
observed in p63þ/L514F newborn mice. Thus, skin erosions in
patients may be the consequence of a variety of molecular 2012 EMBO Molecular Medicine 201
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202defects, and additional research will be required to establish the
nature of these defects in humans.
In humans, heterozygous deletion of the p63 gene does not
cause clinical features typical of AEC syndrome (Chitayat et al,
1996). Similarly, p63 heterozygous mice are not affected by cleft
palate or epidermal hypoplasia and, in contrast to p63/ mice,
have normal levels of Fgfr2b and Fgfr3b suggesting that
mutations in the SAM domain do not lead to haploinsufficiency
(Candi et al, 2007; Fomenkov et al, 2003; Laurikkala et al, 2006).
Previous overexpression studies in vitro have shown that p63
AEC mutants have dominant negative activities towards wild-
type DNp63a (Koster et al, 2009; Lopardo et al, 2008; Marinari
et al, 2009) and that Fgfr2b expression is affected by p63 at the
RNA and protein levels (Wu et al, 2003). Consistent with these
reports, we found that in p63þ/L514F mutant epidermis and
keratinocytes, a large number of p63 target genes, including
Fgfr2 and Fgfr3 are affected, suggesting a broad dominant-
negative function of AEC mutants. p63 directly regulates Fgfr2
and Fgfr3 transcription by binding to several regulatory regions
in the Fgfr2 and the Fgfr3 loci, and Fgfr2 primary transcripts are
affected in p63þ/L514F keratinocytes, suggesting that an impor-
tant level of dysregulation in AEC syndrome occurs at the
transcriptional level. Interestingly, the repressive function of
p63 on several cell cycle regulators, which has been shown to
occur through interactions with histone deacetylase 1 (HDAC1)
and histone deacetylase 2 (HDAC2) (Leboeuf et al, 2011), is not
altered by the AECmutation. Howmutations in the SAM domain
selectively affect a subset of target genes remains an open
question for future studies and will require identification of
more SAM domain-binding partners.MATERIALS AND METHODS
Generation of p63R/L514F mice
The generation of knock-in mice is described in Supporting informa-
tion. 129/C57BL/6 p63L514F chimeric males were bred with C57BL/6
female mice to generate p63þ/L514F offspring. For NEO cassette
removal, chimeras were bred with CMV-Cre transgenic mice in a
C57BL/6 background. An indistinguishable phenotype was observed
with and without the NEO cassette. Fgfr2b/ mice have been
described previously (De Moerlooze et al, 2000). All mouse experi-
ments were approved by the Italian Ministry of Health.
Histology, Immunostaining and Immunoblotting
Mouse tissue was fixed in 4% PFA and embedded in paraffin wax. To
evaluate cell proliferation, 5-bromo-20-deoxy-uridine (BrdU, Invitro-
gen) was injected 3 h before the animals were sacrificed. Immuno-
fluorescence was performed as described previously (De Rosa et al,
2009). Fluorescent signals were monitored under a Zeiss Axioskop2
plus image microscope or under a Zeiss confocal microscope
LSM510meta. Human skin samples were obtained from previously
described AEC patients (Dishop et al, 2009). Patient mutations have
been reported (Rinne et al, 2009), and are listed in Table S3 of
Supporting Information. For three-dimensional computer-aided re-
construction of the tooth, 5mm serial paraffin sections of E18.5 heads
were cut and stained with haematoxylin & eosin (H&E). The contour of 2012 EMBO Molecular Medicinethe first lower molar was drawn at the epithelial–mesenchymal
junction and reconstructed using BioVis3D software (BioVis3D,
Uruguay). For immunoblotting, P0 epidermis was obtained by floating
skin biopsies in 0.5M ammonium thiocyanate (NH4SCN) in phosphate
buffer, pH 6.8 for 20min on ice. Tissue was pulverized in liquid
nitrogen, lysed in sample buffer and immunoblotted as previously
described (De Rosa et al, 2009). Antibodies used in this study are listed
in Supporting information.
Cell and tissue culture, clonogenic assay and FACS analysis
Newborn mouse skin was placed in dispase o/n at 4 8C, and then
keratinocytes were isolated from epidermis by enzymatic dissociation
in trypsin, and cultured in defined PCT-epidermal keratinocyte medium
(CnT-07, CELLnTEC) as described previously (Strachan et al, 2008). For
clonogenic assays 103 cells/cm2 were plated on 35mm dishes
previously coated with 0.5mg of Matrigel (BD Bioscience), and cultured
in CnT-07. After 3 weeks, clones were stained with Crystal Violet
(Sigma) and manually counted or picked individually for a secondary
and tertiary plating in order to test their self-renewal ability.
For FACS analysis, freshly isolated newborn keratinocytes were
prepared by enzymatic dissociation as above, and were stained with
the indicated antibodies and with the vital dye Sytox Blue (Invitrogen)
to exclude dead cells from the analysis. Samples were analyzed with
FACSCanto II flow cytometry system (BD Biosciences) using BD
FACSDIVA software. For the in vitro palatal shelves fusion assay,
E13.5 palatal shelves were dissected and cultured in intimate contact
on Millipore filters placed on metal grids in Trowell dishes, in DMEM/
F12 as previously described (Thomason et al, 2008). For rescue
experiments, primary keratinocytes were seeded on 12-well plates
and infected with pBabe-Fgfr2b-C3 (Cha et al, 2009) or empty vector.
After 2 days, cells were starved for 36 h and then treated with KGF
(10 ng/ml). After 10min, protein extracts were collected and
samples were analyzed by immunoblotting. To evaluate proliferation,
cells were incubated with BrdU labelling reagent 20 h after KGF
treatment.
Real-time RT-PCR and ChIP analysis
Mouse epidermis was isolated from dermis by thermal shock at
55 8C for 1min. RNA was extracted in TRIzol reagent (Invitrogen).
Three millimeter human skin biopsies were obtained from AEC
patients and stored in RNAlater. Total RNA was isolated from
one-fourth of a 3mm skin biopsy using RNeasy mini kits (Qiagen).
Nuclear RNA was purified using Cytoplasmic & Nuclear RNA
Purification Kit (Norgen) and treatment with DNase I (Roche).
Complementary DNA (cDNA) synthesis was obtained using SuperScript
Vilo (Invitrogen).
Real-time PCR was performed using the SYBR Green PCR master mix
(Applied Biosystems) in an ABI PRISM 7500 (Applied Biosystems).
Expression of target genes was normalized for Actb or for RPLP0 for
mouse and human samples, respectively. ChIP analysis was performed
as previously described (De Rosa et al, 2009). For antibodies and
primer sequences see Supporting information and Table S4 of
Supporting Information.
Luciferase reporter assay
Luciferase reporter constructs encompassing p63 binding regions in
Fgfr2 intron 1 (422bp) and at 10 kb (258 bp) from TSS of Fgfr3,EMBO Mol Med 4, 192–205 www.embomolmed.org
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The paper explained
PROBLEM:
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome is
an autosomal dominant disorder mainly characterized by cleft
palate, and ectodermal dysplasia associated with severe
involvement of the skin at birth, whose consequences are life-
threatening. It is caused by heterozygous mutations in the p63
gene, encoding a transcription factor essential for the devel-
opment of several stratified epithelia. Full understanding of AEC
syndrome is impaired by genetic and clinical variability among
unrelated patients, and by lack of foetal or neonatal biological
samples.
RESULTS:
Our article reports the characterization of a knock-in mouse
model for AEC syndrome that recapitulates the human disorder
both at the genetic and phenotypic levels. The p63 AEC mutation
exerts a selective dominant-negative function on wild-type p63
by affecting the expression of a number of p63 target genes,
including Fgfr2 and Fgfr3. Impairment of FGF signalling in p63
mutant embryos causes epidermal hypoplasia and cleft palate
due to reduced expansion of ectodermal progenitor cells. These
phenotypes are associated with a defective stem cell compart-
ment that is observed not only in AEC mutant mice and in mice
lacking epithelial Fgfr2, but also in humans affected by AEC
syndrome.
IMPACT:
Our studies provide novel mechanistic insights into the
pathogenesis of AEC syndrome and establish a functional link
between FGF signalling and p63 in the expansion of epithelial
progenitor cells during embryonic development, a step required
for skin and palate morphogenesis. Moreover, our observations
provide the first evidence that reduced FGF signalling during
embryogenesis leads to defects in the epidermal stem cell
compartment.were cloned in pGL3 basic vector (Promega). Mutagenesis was
obtained using QuikChange site-directed mutagenesis (Stratagene).
H1299 cells were transiently co-transfected with reporter and CMV-
FLAG-DNp63a or empty vector, and pTK-Renilla (10 ng). Luciferase
activity was determined 48 h after transfection with the dual-
luciferase reporter assay kit (Promega).Author contributions
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